Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New PubMed-listed publication citation was added to the Publications section (Cancer Res Commun. 2026) for the study. A PubMed auto-fill note with revision 3.6.4 was also included, clarifying the source of automatically pulled text.
    Difference
    0.2%
    Check dated 2026-07-25T13:13:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated to Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor metadata update to the page without changing study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:17.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.0 to v3.6.2, reflecting a newer build version.
    Difference
    0.1%
    Check dated 2026-06-27T01:05:27.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    New user guidance and join-related navigation items have been added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). The label formatting for Intervention/Treatment was updated, and a site revision note (Revision: v3.6.0) is shown.
    Difference
    0.5%
    Check dated 2026-06-12T14:29:15.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now displayed, replacing v3.5.4. This reflects a small update to the page's version/build tag rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T09:23:38.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed, reflecting a version update on the page. This metadata change updates the page's revision number but does not modify the study content.
    Difference
    0.1%
    Check dated 2026-05-14T23:18:46.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.